PMID: 326816Jun 1, 1977Paper

Modification of the microimmunofluorescence test to provide a routine serodiagnostic test for chlamydial infection

Journal of Clinical Pathology
J D TreharneB R Jones

Abstract

A modification of the microimmunofluorescence test to provide a practicable routine serodiagnostic test for detecting and characterising chlamydial infection is described which uses four antigen pools, one of which corresponds with each of the four main clinical and epidemiological types of chlamydial infection. The three subgroup A Chlamydia (Chlamydia trachomatis) pools are: pool 1, hyperendemic trachoma TRIC agent serotypes A, B, and C; pool 2, paratrachoma TRIC agent serotypes D, E, F, G, H, I, and K; pool 3, lymphogranuloma venereum (LGV) agent serotypes L1, L2, and L3. Pool 4 contained four representative isolates of subgroup B Chlamydia (Chlamydia psittaci). For routine purposes sera need be screened only against these four representative antigen pools. This will detect antibody and indicate which clinical and epidemiological type of chlamydial infection is implicated, thereby clearly distinguishing those infections that are due to C. psittaci. The pattern of the cross-reactions may indicate the individual serotype involved, and further titration requiring a maximum of four individual antigens is sufficient to determine the serotype. The slight loss in sensitivity (twofold) is more than compensated for by the reduction i...Continue Reading

References

Sep 1, 1975·Child: Care, Health and Development·B Jay
Jun 1, 1973·The British Journal of Venereal Diseases·J D TreharneB R Jones
Oct 1, 1974·The Journal of Infectious Diseases·S P Wang, J T Grayston
Sep 1, 1969·Journal of Bacteriology·J Schachter, K F Meyer

❮ Previous
Next ❯

Citations

Sep 1, 1985·Journal of in Vitro Fertilization and Embryo Transfer : IVF·G F RowlandS Darougar
Jan 1, 1982·Infection·J D Treharne
Jan 1, 1982·Infection·L Weström
Jun 1, 1994·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·D KeseM Cizman
Oct 1, 1986·European Journal of Clinical Microbiology·K Persson, M Bröms
Feb 1, 1983·European Journal of Clinical Microbiology·P Duc-GoiranJ Orfila
Jan 1, 1983·Social Science & Medicine·R C BallardJ D Treharne
May 1, 1995·Public Health·A Davies, T Collins
Apr 26, 1980·Lancet·P Wølner-HanssenP A Mårdh
Mar 31, 1984·Lancet·J L KaneT Forsey
Feb 1, 1997·Social Science & Medicine·M E DuncanE Roggen
Jun 1, 1990·Epidemiology and Infection·T G WreghittR B Buttery
Jan 1, 1989·Eye·A N ElbagirP A Mårdh
Apr 9, 1981·The New England Journal of Medicine·E B Myhre, P A Mårdh
Mar 3, 2001·Human Reproduction·A P GijsenJ L Evers
Mar 1, 1990·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·A Elbagir, P A Mårdh
Jul 1, 1990·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·A ElbagirP A Mårdh
Jan 1, 1991·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·B HerrmannP A Mårdh
Jun 1, 1986·Archives of Disease in Childhood·K PerssonS Polberger
Aug 1, 1978·The British Journal of Ophthalmology·S DarougarB R Jones
Nov 1, 1979·The British Journal of Ophthalmology·D J SpaltonT Forsey
Feb 1, 1981·The British Journal of Ophthalmology·T Forsey, S Darougar
Jun 1, 1984·The British Journal of Ophthalmology·T Forsey, S Darougar
Oct 1, 1988·The British Journal of Ophthalmology·S Darougar, N D Viswalingam
Nov 4, 1978·British Medical Journal·P D GriffithsJ D Treharne
May 22, 1982·British Medical Journal·D Hobson, E Rees
Feb 12, 1983·British Medical Journal·J M GoldmanR M Perinpanayagam
Nov 28, 1987·British Medical Journal·J WinceslausJ D Treharne
Jan 1, 1981·Gut·P R ElliottJ E Lennard-Jones
Mar 1, 1980·Journal of Clinical Pathology·D Taylor-Robinson, B J Thomas
Jan 1, 1991·Journal of Clinical Pathology·G L Ridgway, D Taylor-Robinson
Apr 1, 1993·Journal of Clinical Pathology·C Y Tong, M Sillis
Oct 1, 1978·The British Journal of Venereal Diseases·P A MårdhS Darougar
Dec 1, 1978·The British Journal of Venereal Diseases·J D TreharneR N Thin
Feb 1, 1979·The British Journal of Venereal Diseases·J D TreharneS Darougar
Aug 1, 1979·The British Journal of Venereal Diseases·J R WillcoxD Barlow
Dec 1, 1979·The British Journal of Venereal Diseases·P D SimmonsR K Pandhi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The British Journal of Venereal Diseases
J D TreharneR N Thin
The British Journal of Venereal Diseases
S DarougarK L Rogers
The British Journal of Venereal Diseases
M D AlaniH Dunn
© 2021 Meta ULC. All rights reserved